ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 52 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2018. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $26,000 | -99.9% | 12,240 | -12.2% | 0.14% | -8.8% |
Q4 2018 | $31,365,000 | +40633.8% | 13,940 | -36.5% | 0.16% | -52.5% |
Q3 2018 | $77,000 | +8.5% | 21,940 | 0.0% | 0.34% | -26.9% |
Q2 2018 | $71,000 | -7.8% | 21,940 | 0.0% | 0.46% | +26.9% |
Q1 2018 | $77,000 | -24.5% | 21,940 | -4.9% | 0.36% | -16.2% |
Q4 2017 | $102,000 | +34.2% | 23,073 | +59.1% | 0.43% | +38.6% |
Q3 2017 | $76,000 | -79.4% | 14,500 | -79.6% | 0.31% | -82.4% |
Q2 2017 | $369,000 | +103.9% | 70,934 | +66.5% | 1.77% | +101.7% |
Q1 2017 | $181,000 | +43.7% | 42,600 | +6.5% | 0.88% | +71.0% |
Q4 2016 | $126,000 | +75.0% | 40,000 | +90.5% | 0.51% | +92.1% |
Q3 2016 | $72,000 | – | 21,000 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Greenlight Capital | 1,000,000 | $1,100,000 | 0.07% |
Hayden Royal, LLC | 40,015 | $44,000 | 0.02% |
Verdence Capital Advisors LLC | 143,382 | $158,000 | 0.02% |
Founders Capital Management | 18,000 | $20,000 | 0.01% |
WOLFF WIESE MAGANA LLC | 10,740 | $12,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 1,622,510 | $1,785,000 | 0.01% |
Global Strategic Investment Solutions, LLC | 23,000 | $25,000 | 0.00% |
Stonebridge Capital Advisors LLC | 44,000 | $45,000 | 0.00% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $110,000 | 0.00% |
PRELUDE CAPITAL MANAGEMENT, LLC | 97,590 | $107,000 | 0.00% |